메뉴 건너뛰기




Volumn 19, Issue 4, 2001, Pages 954-959

Influences on oncologists' adoption of new agents in adjuvant chemotherapy of breast cancer

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; PACLITAXEL;

EID: 0035865429     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.4.954     Document Type: Article
Times cited : (16)

References (15)
  • 1
    • 0032547564 scopus 로고    scopus 로고
    • Polychemotherapy for early breast cancer: An overview of the randomised trials
    • (1998) Lancet , vol.352 , pp. 930-942
  • 2
    • 0001261990 scopus 로고    scopus 로고
    • Improved disease-free and overall survival from the addition of sequential paclitaxel but not from the escalation of doxorubicin dose level in the adjuvant chemotherapy of patients with node-positive primary breast cancer
    • abstr 390A
    • (1998) Proc Am Soc Clin Oncol , vol.17
    • Henderson, I.C.1    Berry, D.2    Demetri, G.3
  • 3
  • 4
    • 10344252760 scopus 로고    scopus 로고
    • Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: An analysis of two intergroup trials
    • (1996) J Clin Oncol , vol.14 , pp. 3009-3017
    • Albain, K.S.1    Green, S.R.2    Lichter, A.S.3
  • 8
    • 0003190701 scopus 로고    scopus 로고
    • Mastectomy or lumpectomy? The choice of operation for clinical stages I and II breast cancer
    • (1998) Can Med Assoc J , vol.159 , pp. 15-21
    • Committee, S.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.